Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(6 sites)
Spain
Hospital Universitario del Henares, Coslada, Madrid Fundación Jiménez Díaz, Madrid, Madrid Hospital Universitario Doce de Octubre, Madrid, Madrid Hospital Universitario Rey Juan Carlos, Móstoles, Madrid Hospital Universitario Infanta Elena, Valdemoro, Madrid Hospital Universitario General de Villalba., Villalba, Madrid